{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:12:13Z","timestamp":1773259933768,"version":"3.50.1"},"reference-count":70,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAR"],"DOI":"10.2147\/cmar.s201024","type":"journal-article","created":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T22:18:35Z","timestamp":1611526715000},"page":"677-692","source":"Crossref","is-referenced-by-count":19,"title":["Copanlisib in the Treatment of Relapsed Follicular Lymphoma: Utility and Experience from the Clinic"],"prefix":"10.2147","volume":"Volume 13","author":[{"given":"Ayushi F","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6246-4308","authenticated-orcid":true,"given":"Bruce D","family":"Cheson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,1]]},"reference":[{"key":"ref1","unstructured":"Sundar H, Fakhri B, Fayad LE, et al. NCCN guidelines version 1.2020 B-cell lymphomas NCCN evidence blocks TM continue NCCN guidelines panel disclosures \u03be bone marrow transplantation \u2021 hematology\/hematology oncology \u00de internal medicine \u2020 medical oncology \u2260 pathology \u00a5 patient advocacy \u00a7 radiotherapy\/radiation oncology * Discussion writing committee member. 2020."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41408-020-00340-z","volume":"10","author":"Batlevi","year":"2020","journal-title":"Blood Cancer J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1535-7163.MCT-08-0801","volume":"8","author":"Ihle","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1038\/onc.2008.245","volume":"27","author":"Yuan","year":"2008","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.seminoncol.2016.11.011","volume":"43","author":"Pongas","year":"2016","journal-title":"Semin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1182\/blood-2015-08-665141","volume":"126","author":"Strout","year":"2015","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1182\/blood-2015-04-640912","volume":"126","author":"Amin","year":"2015","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1182\/blood-2015-04-640805","volume":"126","author":"Linley","year":"2015","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/leu.2014.91","volume":"28","author":"Hiddemann","year":"2014","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1182\/blood-2006-05-026203","volume":"108","author":"Leseux","year":"2006","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00280","volume":"3","author":"Mourcin","year":"2012","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.molimm.2009.03.010","volume":"46","author":"Dil","year":"2009","journal-title":"Mol Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1084\/jem.20072327","volume":"205","author":"Guo","year":"2008","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1182\/blood-2010-02-271171","volume":"116","author":"Herman","year":"2010","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.2147\/DDDT.S142406","volume":"12","author":"Krause","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.7150\/jca.11279","volume":"6","author":"Dong","year":"2015","journal-title":"J Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1158\/1078-0432.CCR-14-2034","volume":"21","author":"Yang","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/jamaoncol.2019.3994","volume":"6","author":"Bird","year":"2020","journal-title":"JAMA Oncol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1200\/JCO.18.00915","volume":"37","author":"Flinn","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1158\/1535-7163.MCT-12-0993-T","volume":"12","author":"Liu","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"ref23","unstructured":"Fda, Cder. Highlights of prescribing information. [cited July 12, 2020]. Available from: www.fda.gov\/medwatch."},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Gerisch M,\u00a0 Schwarz T,\u00a0 Lang D, et al. Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14 C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers. Cancer Chemother Pharmacol. 2017 Sep;80(3):535\u2013544. doi:10.1007\/s00280-017-3383-9","DOI":"10.1007\/s00280-017-3383-9"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ccell.2016.12.003","volume":"31","author":"Paul","year":"2017","journal-title":"Cancer Cell"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/annonc\/mdw282","volume":"27","author":"Patnaik","year":"2016","journal-title":"Ann Oncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00280-016-3198-0","volume":"79","author":"Doi","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1158\/1078-0432.CCR-14-1306","volume":"21","author":"Shapiro","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/annonc\/mdx289","volume":"28","author":"Dreyling","year":"2017","journal-title":"Ann Oncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1182\/blood-2013-11-538546","volume":"123","author":"Flinn","year":"2014","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1056\/NEJMoa1314583","volume":"370","author":"Gopal","year":"2014","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1200\/JCO.2017.75.4648","volume":"35","author":"Dreyling","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25711","volume":"95","author":"Dreyling","year":"2020","journal-title":"Am J Hematol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"CT212","DOI":"10.1158\/1538-7445.AM2015-CT212","author":"Nowakowski","year":"2015","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.clml.2018.11.021","volume":"19","author":"Cheson","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1158\/2159-8290.CD-18-1175","volume":"9","author":"Hanker","year":"2019","journal-title":"Cancer Discov"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1182\/blood-2019-131779","volume":"134","author":"Zinzani","year":"2019","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1158\/1535-7163.MCT-19-0466","volume":"19","author":"Morschhauser","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1182\/blood-2018-99-117063","volume":"132","author":"Zinzani","year":"2018","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","volume":"560","author":"Hopkins","year":"2018","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1200\/JCO.2011.39.7356","volume":"30","author":"Busaidy","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","volume":"33","author":"Casulo","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/cam4.1918","volume":"8","author":"Lansigan","year":"2019","journal-title":"Cancer Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1182\/blood.V126.23.2744.2744","volume":"126","author":"Gopal","year":"2015","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/hon.57_2631","volume":"37","author":"Dreyling","year":"2019","journal-title":"Hematol Oncol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1182\/blood-2016-02-702761","volume":"128","author":"Cheah","year":"2016","journal-title":"Blood"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1182\/blood-2012-10-460832","volume":"121","author":"Iyengar","year":"2013","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1182\/blood.V126.23.2482.2482","volume":"126","author":"Sorensen","year":"2015","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.18553\/jmcp.2019.18259","volume":"25","author":"Appukkuttan","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"Federico","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1182\/blood.V126.23.333.333","volume":"126","author":"Vindi","year":"2015","journal-title":"Blood"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1470-2045(18)30102-5","volume":"19","author":"Huet","year":"2018","journal-title":"Lancet Oncol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/bjh.16159","volume":"188","author":"Lockmer","year":"2020","journal-title":"Br J Haematol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/asheducation-2018.1.189","volume":"2018","author":"Nastoupil","year":"2018","journal-title":"Hematol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1182\/blood.2019000905","volume":"134","author":"Hirayama","year":"2019","journal-title":"Blood"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"16259","DOI":"10.18632\/oncotarget.15180","volume":"8","author":"Modi","year":"2017","journal-title":"Oncotarget"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1200\/JCO.2015.65.9789","volume":"34","author":"Lesokhin","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature13444","volume":"510","author":"Ali","year":"2014","journal-title":"Nature"},{"key":"ref60","first-page":"1541","volume":"130","author":"Pachter","year":"2017","journal-title":"Blood"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"B105","DOI":"10.1158\/1535-7163.TARG-19-B105","author":"Coyne","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/S2352-3026(17)30028-5","volume":"4","author":"Smith","year":"2017","journal-title":"Lancet Haematol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(16)30671-4","volume":"18","author":"Zelenetz","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1182\/blood-2015-12-683516","volume":"127","author":"Barr","year":"2016","journal-title":"Blood"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e1593","DOI":"10.1038\/cddis.2014.525","volume":"6","author":"Choudhary","year":"2015","journal-title":"Cell Death Dis"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1182\/bloodadvances.2019000844","volume":"4","author":"Tarantelli","year":"2020","journal-title":"Blood Adv"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S1470-2045(18)30082-2","volume":"19","author":"Burris","year":"2018","journal-title":"Lancet Oncol"},{"key":"ref68","unstructured":"Davids M, Flinn I, Mato A. Long term integrated safety analysis of umbralisib (TGR-1202), a PI3K-delta\/CK1-epsilon inhibitor with a differentiated safety profile, in patients with relapsed\/refractory lymphoid malignancies. 2018 cited October 1, 2020]. Available from: https:\/\/library.ehaweb.org\/eha\/2018\/stockholm\/214906\/matthew.s.davids.md.mmsc.long.term.integrated.safety.analysis.of.umbralisib.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dunity."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"8016","DOI":"10.1200\/JCO.2020.38.15_suppl.8016","volume":"38","author":"Zelenetz","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1200\/JCO.2019.37.15_suppl.7512","volume":"37","author":"Zelenetz","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["Cancer Management and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=65936","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=65936","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T03:27:37Z","timestamp":1670902057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/copanlisib-in-the-treatment-of-relapsed-follicular-lymphoma-utility-an-peer-reviewed-article-CMAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":70,"URL":"https:\/\/doi.org\/10.2147\/cmar.s201024","relation":{},"ISSN":["1179-1322"],"issn-type":[{"value":"1179-1322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}